356 related articles for article (PubMed ID: 27672078)
1. Efficacy of Treatment of Non-hereditary Angioedema.
van den Elzen M; Go MFCL; Knulst AC; Blankestijn MA; van Os-Medendorp H; Otten HG
Clin Rev Allergy Immunol; 2018 Jun; 54(3):412-431. PubMed ID: 27672078
[TBL] [Abstract][Full Text] [Related]
2. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
Culley CM; DiBridge JN; Wilson GL
Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
[TBL] [Abstract][Full Text] [Related]
3. Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.
Riha HM; Summers BB; Rivera JV; Van Berkel MA
J Emerg Med; 2017 Nov; 53(5):662-679. PubMed ID: 28939396
[TBL] [Abstract][Full Text] [Related]
4. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
Jeon J; Lee YJ; Lee SY
J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
[TBL] [Abstract][Full Text] [Related]
5. Angioedema: etiology, pathophysiology, current and emerging therapies.
Lewis LM
J Emerg Med; 2013 Nov; 45(5):789-96. PubMed ID: 23992848
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.
Scalese MJ; Reinaker TS
Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237
[TBL] [Abstract][Full Text] [Related]
7. Novelties in the Diagnosis and Treatment of Angioedema.
Cicardi M; Suffritti C; Perego F; Caccia S
J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
[TBL] [Abstract][Full Text] [Related]
8. Icatibant for the treatment of hereditary angioedema.
Cole SW; Lundquist LM
Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for idiopathic angioedema.
Shroba J; Hanson J; Portnoy J
Ann Allergy Asthma Immunol; 2015 Nov; 115(5):429-33. PubMed ID: 26341649
[TBL] [Abstract][Full Text] [Related]
10. [Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors].
Beauchêne C; Martins-Héricher J; Denis D; Martin L; Maillard H
Rev Med Interne; 2018 Oct; 39(10):772-776. PubMed ID: 29735174
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitor-mediated angioedema.
Montinaro V; Cicardi M
Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
[TBL] [Abstract][Full Text] [Related]
12. Large Predominance of Off-Label Prescriptions of C1-Inhibitor Concentrates and Icatibant in a Real-Life Setting: A Retrospective Clinical Study.
Rocour S; Cochard B; Daniel V; Martin L; Corvaisier M
J Clin Pharmacol; 2023 Jan; 63(1):29-39. PubMed ID: 35871284
[TBL] [Abstract][Full Text] [Related]
13. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of human C1 esterase inhibitor concentrate for treatment of ACE-inhibitor induced angioedema.
Strassen U; Bas M; Wirth M; Wirth M; Gröger M; Stelter K; Volkenstein S; Kehl V; Kojda G; Hoffmann TK; Hahn J; Trainotti S; Greve J
Am J Emerg Med; 2023 Feb; 64():121-128. PubMed ID: 36516670
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
16. Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.
Schulkes KJG; Van den Elzen MT; Hack EC; Otten HG; Bruijnzeel-Koomen CAFM; Knulst AC
Clin Transl Allergy; 2015; 5(1):5. PubMed ID: 25664168
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
Hirschy R; Shah T; Davis T; Rech MA
Adv Emerg Nurs J; 2018; 40(4):267-277. PubMed ID: 30365440
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid use in the setting of ACE inhibitor induced angioedema.
Stoldt J; Cox C; Matusz E
Am J Emerg Med; 2022 May; 55():230.e3-230.e4. PubMed ID: 35105472
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review.
Lawlor CM; Ananth A; Barton BM; Flowers TC; McCoul ED
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):232-239. PubMed ID: 29112487
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic Acid for the Emergency Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema.
Hasara S; Wilson K; Amatea J; Anderson J
Cureus; 2021 Sep; 13(9):e18116. PubMed ID: 34692327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
